VLG.LSE Venture Life Group PLC

Consumer Defensive Personal Care Products London Exchange
0.6900 GBX
Close of Nov 2, 2026
53.00 72.00
Market cap
GBX 82.0M
P/E
-
P/B
1.09x
ROE
7.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is VLG.LSE undervalued?

Graham number

The Graham number of Venture Life Group PLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Venture Life Group PLC fundamental analysis

No fundamental analysis for Venture Life Group PLC yet.

Venture Life Group PLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Venture Life Group PLC

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women's healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatm…

Full company profile